Market Value123,887,533
Total Holdings52
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACET / Adicet Bio, Inc.
HLVX / HilleVax, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
IKT / Inhibikase Therapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
APRE / Aprea Therapeutics, Inc.
AQST / Aquestive Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
ADMA / ADMA Biologics, Inc.
ANIK / Anika Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
KZR / Kezar Life Sciences, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
ELEV / Elevation Oncology, Inc.
XOMA / XOMA Royalty Corporation
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
OPTN / OptiNose, Inc.
ANIP / ANI Pharmaceuticals, Inc.
INDV / Indivior PLC
TENX / Tenax Therapeutics, Inc.
OPTN / OptiNose, Inc.
FNA / Paragon 28, Inc.
ALIMERA SCIENCES INC CVR / (016CVR029)
ENTA / Enanta Pharmaceuticals, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
KPRX / Kiora Pharmaceuticals, Inc.
MIST / Milestone Pharmaceuticals Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
RVNC / Revance Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
JAZZ / Jazz Pharmaceuticals plc
TELA / TELA Bio, Inc.
TSVT / 2seventy bio, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ALLR / Allarity Therapeutics, Inc.
XGN / Exagen Inc.
RPRX / Royalty Pharma plc
VIRX / Viracta Therapeutics, Inc.
MYO / Myomo, Inc.
ZVRA / Zevra Therapeutics, Inc.
PYPD / PolyPid Ltd.
VNDA / Vanda Pharmaceuticals Inc.
CHRS / Coherus Oncology, Inc.
EOLS / Evolus, Inc.
XERS / Xeris Biopharma Holdings, Inc.
SRZN / Surrozen, Inc.
ESTA / Establishment Labs Holdings Inc.
VSTM / Verastem, Inc.
INO / Inovio Pharmaceuticals, Inc.
ANTX / AN2 Therapeutics, Inc.
AYTU / Aytu BioPharma, Inc.
URGN / UroGen Pharma Ltd.
SCPH / scPharmaceuticals Inc.
HRTX / Heron Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
PROF / Profound Medical Corp.
CALC / CalciMedica, Inc.
SLRN / Acelyrin, Inc.